BackNeuBase Therapeutics Overview

NeuBase Therapeutics Selling, General & Admin

Selling, General & Admin expenses for NBSE.

Quarterly SG&A Expenses

$1.20M
↓ 46.21% YoY

As of Sep 30, 2023

Annual SG&A Expenses (TTM)

$9.12M
↓ 23.16% YoY

Trailing 12 months ending Sep 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin